Curaleaf Holdings, Inc.
CURLF · OTCMCIK 1756770fmd_1PE6WFE858YD76X5AJH4CQ5RFFManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2019 to Sep 30, 2026, 15 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Total revenues | 221 | 627 | 1,196 | 1,275 | 1,347 | 1,334 | 1,268 |
| Cost of revenue | 102 | 311 | 626 | 649 | 732 | 694 | 637 |
| Gross profit | 142 | 391 | 570 | 626 | 614 | 641 | 631 |
| Realized investment gains (losses) | – | – | – | – | – | (2) | (1) |
| Research and development | – | – | – | – | – | 1 | 1 |
| Selling, general and administrative | 121 | 227 | 387 | 420 | 415 | 419 | 428 |
| Compensation and benefits | – | – | 203 | 211 | 207 | 228 | 231 |
| Total operating expenses | – | – | 511 | 561 | 572 | 616 | 606 |
| Operating income | (28) | 72 | 59 | 65 | 43 | 25 | 25 |
| Interest expense | 18 | 48 | 54 | – | 54 | 53 | 54 |
| Other non-operating income (expense) | – | – | (121) | (151) | (167) | (138) | (104) |
| Income before taxes | (46) | 31 | (62) | (86) | (124) | (113) | (78) |
| Income tax expense | 24 | 88 | 152 | 179 | 115 | 98 | 124 |
| Net income from continuing operations | (70) | (57) | (215) | (265) | (239) | (212) | (202) |
| Net income | (67) | (57) | (206) | (370) | (281) | (215) | (231) |